Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 25,000 Shares

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $58.65, for a total value of $1,466,250.00. Following the sale, the chief executive officer owned 1,148,095 shares of the company’s stock, valued at $67,335,771.75. This represents a 2.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $57.04, for a total value of $1,426,000.00.
• On Wednesday, May 13th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $56.29, for a total value of $1,407,250.00.
• On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $41.50, for a total value of $1,037,500.00.
• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $42.09, for a total value of $1,052,250.00.
• On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.10, for a total value of $1,002,500.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total value of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total value of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total value of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total value of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total value of $859,891.96.

Liquidia Stock Up 3.0%

NASDAQ:LQDA traded up $1.79 during mid-day trading on Wednesday, reaching $61.77. The stock had a trading volume of 1,754,852 shares, compared to its average volume of 1,713,171. The company has a market capitalization of $5.49 billion, a price-to-earnings ratio of 441.25 and a beta of 0.41. Liquidia Corporation has a 1-year low of $11.85 and a 1-year high of $62.17. The stock’s 50 day simple moving average is $40.63 and its two-hundred day simple moving average is $36.54. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. The business had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.Liquidia’s revenue for the quarter was up 4187.1% compared to the same quarter last year. Equities analysts anticipate that Liquidia Corporation will post 2.97 EPS for the current year.

Hedge Funds Weigh In On Liquidia

Large investors have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia in the fourth quarter worth about $25,000. Covestor Ltd lifted its holdings in Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in Liquidia in the third quarter worth about $30,000. FNY Investment Advisers LLC bought a new position in Liquidia in the third quarter worth about $34,000. Finally, NewEdge Advisors LLC bought a new position in Liquidia in the second quarter worth about $25,000. Institutional investors own 64.54% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on LQDA shares. Jefferies Financial Group reiterated a “buy” rating and issued a $60.00 price target on shares of Liquidia in a research note on Monday, May 11th. HC Wainwright lifted their price target on Liquidia from $55.00 to $67.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Oppenheimer lifted their price target on Liquidia from $16.00 to $19.00 and gave the stock an “underperform” rating in a research note on Thursday, March 12th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. Finally, Wall Street Zen upgraded Liquidia from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Three investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Liquidia currently has a consensus rating of “Moderate Buy” and a consensus target price of $49.33.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).